Brain chips: Neuralink’s surgical robot is intended to ensure mass productiond

Neuralink plans to mass produce its brain implants from 2026 and relies on specially developed robots. The machines are intended to speed up risky operations and minimize human errors in the tissue through high precision.

Robots for brain implants

The neurotechnology company Neuralink plans to mass produce its brain chips starting this year. In order to meet the ever-increasing demand in the future, the complex implantations will be carried out by a specially developed robot. The ultimate goal is to speed up the demanding surgical process while significantly increasing safety for patients with serious neurological diseases. Above all, the system is intended to minimize human errors during interventions. So far around 20 people have received such a device. The early testers, who often suffer from severe physical limitations, control computers or robot arms using their thoughts alone.

Brain-computer interfaces give paralyzed people voice and enable devices to be controlled using brain activity alone. The implant’s flexible threads are thinner than a human hair. Since surgeons are reaching their limits when placing the wires manually, machines are now taking over the high-precision tasks directly in the sensitive tissue. Neuralink shows how you can use robotics to automate your surgical procedure

Precision through automation

How TechEBlog reports, the new robotic system uses eight cameras and an optical coherence tomography scanner. The machine thus monitors the processes beneath the surface of the brain in real time. A team of engineers also equipped the device with five axes. This allows the robot to flexibly adapt to different entry points on the patient’s skull. The automated procedure offers several technical adjustments to increase the efficiency of the interventions. The robot pierces the hard meninges directly instead of having to laboriously remove it. A more compact arm design makes operation easier and increases operation speed. In addition, improved needle designs and optical sensors ensure clean placement of the threads.

fBy eliminating surgical steps, the risk of infection decreases while at the same time making more procedures possible in a shorter time. With a recent financing round of around 650 million dollars (around 557 million euros), the company is rapidly expanding its production capacities. The group’s total valuation is now nine billion dollars (around 7.7 billion euros). The capital flows primarily into the production of the end devices. However, despite technological advances, medical experts express concerns about long-term tolerability.

dA central problem is the so-called glial scar formation. The human immune system recognizes the implant as a foreign body and forms a tissue capsule around the fine electrodes to defend itself. Brain-computer interfaces now work very reliably, but the insulating layer can weaken the electrical signals over time. This reduces the functionality of the device and could result in risky follow-up operations to restore signal transmission. The automation of medical interventions on the brain is progressing rapidly and brings with it both opportunities and risks.